Collaborative Network

Replicor has established collaborations with renowned institutions to bring world class expertise to the testing and development of its NAP technology.

These institutions include:

  • INSERM U1052 (Lyon, France)
  • Institut National de Transfusion Sanguine (Paris, France)
  • Academic Medical Center (Amsterdam, the Netherlands)
  • Universite Francois-Rabelais (INSERM)  (Tours, France)
  • University of Essen, Department of Virology (Essen-Duisberg, Germany)
  • Bangabandhu Sheikh Mujib Medical University (Dhaka, Bangladesh)
  • Baylor College of Medicine (Houston, Texas)
  • Centre National de Référence des Virus Influenza (Lyon, France)
  • Cincinnati Children’s Hospital (Cincinnati, Ohio)
  • Department of Medical Biophysics, University of Toronto (Toronto, Ontario)
  • Hepatitis Viral Research Group, University of Adelaide (Adelaide, Australia)
  • Mt. Sinai School of Medicine (New York, New York)
  • National Microbiology Laboratory (Winnipeg, Manitoba)
  • CHUQ, Laval University (Quebec, Canada)
  • New York Blood Center (New York, New York)
  • NIH / NDDK Liver Disease Institute (Bethesda, Maryland)
  • NIH / NIAID Antiviral testing program (Bethesda, Maryland)
  • Rocky Mountain Labs, NIH (Hamilton, Montana)
  • Southern Research Institute (Birmingham, Alabama)
  • University of Texas Medical Branch (Galveston, Texas)